MT-2271 - Global Drug Overview & Product Profiles, 2019: A Plant-Based, Recombinant Virus-Like Particle (VLP) QIV Seasonal Influenza Vaccine - GlobeNewswire

MT-2271 - Global Drug Overview & Product Profiles, 2019: A Plant-Based, Recombinant Virus-Like Particle (VLP) QIV Seasonal Influenza Vaccine  GlobeNewswire

Dublin, June 28, 2019 (GLOBE NEWSWIRE) -- The "MT-2271" report has been added to ResearchAndMarkets.com's offering. MT-2271 is a plant-based, ...